Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 405)
Posted On: 06/25/2020 3:29:16 PM
Post# of 36568
Posted By: skipper1072
New BARDA Award: Colorado State University USA
Product Name: SolaVAX Vaccine Development
View Announcement


Description:
SolaVAX™ is an inactivated virus vaccine platform that uses Riboflavin and UV light to selectively inactivate virus particles by directed damage to nucleic acids while preserving the integrity of the proteins and viral antigens.


Unique Impact:
This technology will generate a virus particle that contains all the potential antigenic targets for immune response for use in a vaccine without the capacity for replication post-infection.


Award Amount: $699,994.00


Cost Share: Yes













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site